Science Explorer Interactive view Map
Topic · Neurology

Myasthenia Gravis and Thymoma

Myasthenia Gravis and Thymoma is a research topic within Neurology. Science Explorer counts 26k research works in it since 1950. 8.9% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the research related to myasthenia gravis, including its subgroups, clinical correlates, treatment strategies, and the role of autoantibodies. Additionally, it explores the classification and prognosis of thymic tumors, the efficacy of thymectomy, and the epidemiology of these conditions.

  • Myasthenia Gravis
  • Thymic Tumors
  • Autoantibodies
  • MuSK Antibodies
  • Thymectomy
  • Epidemiology
  • Immunotherapy
  • Neuromuscular Junction
  • Classification System
  • Prognosis
Research works
26k
fractional, since 1950
In the world top 10%
2.3k
per year above
Top-10% rate
8.9%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+23%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Myasthenia Gravis and Thymoma research?

By volume, the United States and China publish the most (925 and 581 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 925 works
  2. 2 China 581 works
  3. 3 Japan 366 works
  4. 4 India 245 works
  5. 5 Italy 201 works
  6. 6 United Kingdom 170 works
  7. 7 Germany 161 works
  8. 8 France 117 works
  9. 9 Türkiye 111 works
  10. 10 Spain 102 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 31.0%China: 19.5%Japan: 12.3%India: 8.2%6 others listed: 28.9%31%largest
United States925 · 31.0%China581 · 19.5%Japan366 · 12.3%India245 · 8.2%6 others listed862 · 28.9%

Shares of the rows listed above, not of the whole node.

Which institutions lead Myasthenia Gravis and Thymoma research?

By volume in 2022–2025, Cleveland Clinic publishes the most Myasthenia Gravis and Thymoma research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and All India Institute of Medical Sciences.

By volume, 2022–2025

  1. 1 Cleveland ClinicUnited States 27 works
  2. 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 17 works
  3. 3 All India Institute of Medical SciencesIndia 16 works
  4. 4 The University of Texas MD Anderson Cancer CenterUnited States 15 works
  5. 5 Sun Yat-sen UniversityChina 15 works
  6. 6 Charité - Universitätsmedizin BerlinGermany 14 works
  7. 7 University of North Carolina at Chapel HillUnited States 14 works
  8. 8 George Washington UniversityUnited States 12 works
  9. 9 Yale UniversityUnited States 12 works
  10. 10 Capital Medical UniversityChina 12 works

Where is Myasthenia Gravis and Thymoma research done?

The largest centres of Myasthenia Gravis and Thymoma research in 2022–2025 are Beijing (China), Tokyo (Japan), Shanghai (China) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Cleveland.

Largest cities, 2022–2025

  1. 1 Beijing China 79 works
  2. 2 Tokyo Japan 76 works
  3. 3 Shanghai China 63 works
  4. 4 Guangzhou China 52 works
  5. 5 Paris France 46 works
  6. 6 London United Kingdom 44 works
  7. 7 New York United States 42 works
  8. 8 Seoul South Korea 41 works
  9. 9 Cleveland United States 37 works
  10. 10 Istanbul Türkiye 37 works

Where it is the local speciality

  1. ClevelandUS · 36.9 works6.4×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Myasthenia Gravis and Thymoma than the world average.

See Myasthenia Gravis and Thymoma on the map

Where is the best place to study Myasthenia Gravis and Thymoma?

Among universities, judged by research, George Washington University, Chiba University and Yale University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 14.78%fractional works in this node (log) →share in the world top 10% →George Washington University: 12, 20.8%Chiba University: 10, 12.2%Yale University: 12, 29.7%Chinese Academy of Medical Sciences & Peking Union Medical College: 17, 4.2%Capital Medical University: 12, 10.3%University of Oxford: 9, 24.1%China Medical University: 8, 19.9%University of North Carolina at Chapel Hill: 14, 11.3%All India Institute of Medical Sciences: 16, 0.6%Fudan University: 10, 14.7%Yale UniversityGeorge Washington Un…Chiba UniversityChinese Academy of M…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 George Washington UniversityUnited States 56.920.8%9.0×12 +9.4%
2 Chiba UniversityJapan 49.012.2%10.7×10 +48.6%
3 Yale UniversityUnited States 47.329.7%3.0×12 -13.8%
4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 41.24.2%4.4×17 +183.1%
5 Capital Medical UniversityChina 40.310.3%5.0×12 +152.0%
6 University of OxfordUnited Kingdom 40.224.1%1.8×9 -1.4%
7 China Medical UniversityChina 39.919.9%6.5×8 +23.7%
8 University of North Carolina at Chapel HillUnited States 37.311.3%2.0×14 +298.3%
9 All India Institute of Medical SciencesIndia 33.60.6%6.8×16 +53.9%
10 Fudan UniversityChina 33.414.7%2.3×10 +96.0%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Myasthenia Gravis and Thymoma research growing?

Output in 2018–2022 was 23% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Myasthenia Gravis and Thymoma.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.